Provided herein are systems for providing therapy to the heart of a patient. The systems include an implantable device for implantation proximate the heart of the patient. The implantable device includes: an anchoring element for maintaining the position of the implantable device after implantation in the patient, at least one sensing electrode for sensing the electrical activity of the heart, at least three pacing electrodes for delivering electrical energy to the tissue of the heart, and a controller including an algorithm for determining when the patient requires therapy. The systems further include an external device having a transceiver for transmitting energy to the implantable device.

An embolization device (10) for promoting clot formation in a bodily lumen and having a contracted delivery configuration and an expanded deployed configuration. The embolization device (10) has a stem (30) and a plurality of flexible bristles (20) extending radially outwardly from the stem (30), the stem (30) comprising: a first wire element (31); a second wire element (32); a tubular interconnect (33) having a lumen and connecting the first wire element (31) to the second wire element (32), the first wire element (31) and the second wire element (32) being disposed within the lumen of the tubular interconnect (33); and a reinforcing sleeve (50) being fixedly disposed over at least part of the tubular interconnect (33) and fixedly disposed over at least part of one or both of the first wire element (31) and the second wire element (32). The reinforcing sleeve (50) has a lower stiffness than the tubular interconnect (33).

Stent-valves (e.g., single-stent-valves and double-stent-valves), associated methods and systems for their delivery via minimally-invasive surgery, and guide-wire compatible closure devices for sealing access orifices are provided.

Methods and devices that prevent stasis in the LAA by either increasing the flow through the LAA or by closing off or sealing the LAA. Increasing the flow is accomplished through shunts, flow diverters, agitators, or by increasing the size of the ostium. Closing off the LAA is accomplished using seals or by cinching the LAA.

An insertable catheter device includes a shaft including a proximal end and a distal end, an expandable balloon, and an actuator configured to expand and retract the expandable balloon. The actuator includes a fluid conduit that extends through the shaft and is coupled with the expandable balloon to enable inflation and retraction of the expandable balloon via injection or withdrawal of a fluid to or from the expandable balloon via the fluid conduit. The expandable balloon is displaceably retractable into the shaft and extendable from the shaft. A fluid pump is coupled with the fluid conduit to pump the fluid through the fluid conduit. A patch is positioned to be displaced by the expandable balloon when the expandable balloon is inflated, and the expandable balloon is displaceably retractable into the shaft and displaceably extendable from the shaft.

A flow blocking catheter including an inner tube, an outer tube and a flow blocking member is provided. The flow blocking member has one end attached to an outer circumference of the inner tube and the other end attached to a distal end of the outer tube. The flow blocking member is configured to expand as the outer tube moves toward a distal end of the inner tube and to collapse as the outer tube moves away from the distal end of the inner tube. In this way, expansion of the flow blocking member is able to be controlled simply by pushing/retracting the outer or inner tube to offer a fast shifting between different configurations. The flow blocking member is able to occlude blood flow with a controllably expansion to lower stimulation to the wall of the blood vessel and avoid the easy bursting of the balloon.

The present technology relates to power management for interatrial shunting systems. In some embodiments, the present technology includes a system for shunting blood between a left atrium and a right atrium of a patient. The system can include a shunting element and a plurality of active electronic components operably coupled to the shunting element. At least some of the active electronic components have different power consumption characteristics. The system also includes a plurality of energy storage components, with some of the energy storage components have different characteristics. During operation, the system is configured to receive a signal indicating that an active electronic component is to be operated, and select an energy storage component associated with power output characteristics capable of accommodating the power consumption characteristics of the active electronic component. The system is further configured to instruct the selected energy storage component to power operation of the active electronic component.

Devices and methods of the disclosure use an intravascular catheter with deployable sealing elements to create a fluid trap around an outlet of a lymphatic duct and drain lymph passively to a collection vessel that may be pressurized to a predetermined pressure or a partial vacuum. Due to the fixed pressure, the device creates a low-pressure area at the lymphatic duct, which drains lymph passively without any mechanical pump or impeller. In certain aspects, a device includes a catheter for insertion into a vein of the venous angle of a patient, with proximal and distal sealing elements deployable to seal the vein to thereby define a fluid trap around the lymphatic outlet. A port within the fluid trap opens to a drainage lumen extending along the catheter to a collection vessel. The device may be configured such that the drainage lumen passively drains the fluid trap into the collection vessel.

Devices and methods are described for occluding the left atrial appendage (LAA). The device excludes the LAA from blood flow to prevent blood from clotting within the LAA and subsequently embolizing, particularly in patients with atrial fibrillation. The implantable device is delivered via transcatheter delivery into the LAA and secured within the LAA. The implant comprises an expandable and compliant frame and an expandable and conformable tubular foam body. The device may have a thromboresistant cover at a proximal end. The frame may have recapture struts inclining radially outwardly from a central hub. The frame may have axially extending side wall struts, with adjacent pairs of side wall struts joined at one or more apexes. Anchors extend from the frame and into the foam to engage tissue.

Methods, devices, and systems for mechanically reducing the volume of the lung. Some embodiments include endobronchially positioning an anchoring device within a lung, the anchoring device comprising at least a distal anchor, expanding at least a portion of the distal anchor to anchor the distal anchor against lung lumen tissue, and tensioning at least a portion of the device to reduce the volume of the lung.